Cite
HARVARD Citation
Ding, H. et al. (2023). Curaxin CBL0137 inhibits endothelial inflammation and atherogenesis via suppression of the Src‐YAP signalling axis. British journal of pharmacology. pp. 1168-1185. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Ding, H. et al. (2023). Curaxin CBL0137 inhibits endothelial inflammation and atherogenesis via suppression of the Src‐YAP signalling axis. British journal of pharmacology. pp. 1168-1185. [Online].